*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
New Insights into Pathogenesis and Immunity of Leishmania Parasites with Emphasis on Vaccines

Author: AISHAH E ALBALAWI, MOHAMED S ALYOUSIF, ABDULLAH D ALANAZI, GHAZAL SHAHROKHI, MARYAM SEPAHVAND, HOSSEIN MAHMOUDVAND, MOHAMMAD REZA NAZER
Abstract: Leishmaniasis is an important group of vector-borne diseases that caused by genus of Leishmania and affect both humans and animals. In this study it has been attempted to review the factors that involved in pathogenesis of Leishmania, immune responses against Leishmania, and the vaccines used in treatment of Leishmania infection. Here we discussed about Leishmania surface molecules–parasite factors (lipophosphoglycan, glycoprotein 63, protein disulfide isomerase, promastigote secretory gel, arginase) in pathogenesis, attachment and entry of parasites to host cells, and host immunity (Neutrophil, macrophages, T and B cells, etc) against Leishmania parasites. The treatment against leishmaniasis are limited with the use of pentavalent antimonials, amphotericin B, etc. But because of the toxicity and high cost of these drugs, the development of effective vaccines is very desirable and efficient. Here we reviewed the new findings about first (Leishvaccine), second (Leishmune, Canileish, and Leish-tech) and third-generation vaccines against leishmaniasis.
Keyword: Leishmaniasis, vaccination, treatment, immunotherapy, immune response
DOI: https://doi.org/10.31838/ijpr/2021.13.02.485
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free